Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

natalie_berner

Redx installs Natalie Berner as Non-Executive Director

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Redx Pharma has appointed Natalie Berner as a Non- Executive Director, she will represent RM Special Holdings 3 LLP on …
Appointment

J&J appoints Charmaine England as MD for Consumer Health Northern Europe

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 
Appointment
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 28, 2021 Medical Communications

Among our ten most-read stories this week: a French study has found that dogs can detect COVID-19 with 97% accuracy, …
News
az

AstraZeneca’s lung cancer drug gains EU approval

May 28, 2021 Medical Communications AstraZeneca, EU, lung cancer, oncology

AstraZeneca’s Tagrisso (osimertinib) has been approved in the EU for the adjuvant treatment of adult patients with early-stage (IB, II …
News

FDA approves BMS’s Zeposia for chronic inflammatory bowel disease

May 28, 2021 Medical Communications

The FDA has approved Approves Bristol Myers Squibb’s Zeposia for adults with moderately to severely active ulcerative colitis (UC). UC …
News
astrazeneca_sign_sky

EU: Fine AstraZeneca €10 per dose for COVID-19 vaccine delay

May 28, 2021 Medical Communications

The EU is suing AstraZeneca in a Brussels court over its failure to deliver on its vaccine contract. EU member …
News

NICE recommends Janssen’s active psoriatic arthritis drug

May 28, 2021 Medical Communications Janssen, NICE, UK, arthritis

NICE have released a Final Appraisal Document (FAD) recommending Janssen’s tremfya (guselkumab) as a new option for treating active psoriatic …
News
janssen_latest_logo_on_sign_closer

NICE rejects Janssen’s prostate cancer drug Erleada

May 21, 2021 Medical Communications

NICE has published has published draft guidance rejecting Janssen’s Erleada (apalutamide) with androgen deprivation therapy (ADT) for treating prostate cancer. …
News

Australian PM calls for domestic mRNA vaccine production

May 21, 2021 Medical Communications Australia, Moderna, Vaccine, mrna

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …
News
international-2693231_1920

Japan approves Moderna & AstraZeneca COVID-19 vaccines

May 21, 2021 Medical Communications COVID-19, Japan, Vaccine

A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …
News

Dogs can detect COVID-19 with 97% accuracy, study finds

May 21, 2021 Medical Communications

A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 21, 2021 Medical Communications

Among our ten most-read stories this week: Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows, while a …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 14, 2021 Medical Communications

Among our ten most-read stories this week: India recoded its record number of COVID-19 deaths, with 4,205 fatalities confirmed in …
News

MSD’s colorectal cancer treatment approved by NICE

May 14, 2021 Medical Communications

Pembrolizumab (Keytruda), for people with untreated metastatic colorectal cancer who have specific mutations in their cancer cells, has been approved …
News
Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

May 14, 2021 Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025